Combotope Therapeutics
A biotechnology company developing tumour-selective antibodies that target cancer-specific glyco-epitopes to improve precision in cancer therapies.
Combotope Therapeutics has raised €500k across 1 funding round from 1 investor, most recently a Debt round in Mar 2026. Based in Kongens Lyngby, Denmark; active in Healthtech. Data as of 28 Oct 2026.
Kongens Lyngby, Denmarkwww.combotopetherapeutics.com ↗
Total raised
€500k
€500,000
Funding rounds
1
Investors
1
distinct backers
Active since
2026-03
latest 2026-03
Funding by year
EUR raised per year · 2026 YTDCombotope Therapeutics — funding by year — interactive chart.
Data table
| Combotope Therapeutics — funding by year | |
|---|---|
| 2026 | €500k |
Signals
High confidenceRaise-next likelihood64
base rate 45% for Debt
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-03-10 | Debt | €500k | BioInnovation Institute | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData